Description
A GPR132 agonist (EC50 = ~400 nM in a PathHunter® β-arrestin assay); inhibits cell growth in a panel of 62 human leukemia cell lines (GI50s = 50s = <78-261 nM); reduces tumor volume in HT-29 and HCT116 mouse xenograft models at 50 mg/kg
Formal name: 2,4,6,7,8,9-hexahydro-7-(phenylmethyl)-4-[[4-(trifluoromethyl)phenyl]methyl]-imidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one
Synonyms:
Molecular weight: 440.5
CAS: 1807861-48-8
Purity: ≥98%
Formulation: A crystalline solid